(Q54000621)
Statements
Phase I trial of inhaled natural interleukin 2 for treatment of pulmonary malignancy: toxicity, pharmacokinetics, and biological effects (English)
Lorenz J
Wilhelm K
Kessler M
Peschel C
Schwulera U
Lissner R
Struff WG
Huland E
Huber C